WEKO3
アイテム
{"_buckets": {"deposit": "5e75abd1-0790-4835-896c-04d515292fcd"}, "_deposit": {"created_by": 1, "id": "46137", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "46137"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00046137", "sets": ["1"]}, "author_link": ["459341", "459340", "459343", "459348", "459347", "459342", "459344", "459346", "459345"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2009-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "195", "bibliographicPageStart": "188", "bibliographicVolumeNumber": "79", "bibliographic_titles": [{"bibliographic_title": "Journal of Reproductive Immunology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Antiphospholipid antibody (aPL) is associated with thromboembolism. There is scant evidence of a relationship between the aPL profile and serious adverse pregnancy outcome. The aim of this study was to assess whether aPL measurements during early pregnancy were useful in predicting a serious adverse pregnancy outcome. In this prospective study, we measured aPLs, including lupus anticoagulant (LA), IgG, IgM, IgA anticardiolipin antibody (aCL), IgG, IgM phosphatidylserine-dependent antiprothrombin antibody, and IgG kininogen-dependent antiphosphatidylethanolamine antibody (aPE) during the first trimester in a consecutive series of 1155 women. The 99 th percentile cut-off values in each aPL were determined using samples from 105 women who did not exhibit any pregnancy morbidity. We assessed the predictive risk of a serious adverse pregnancy outcome adjusted for confounding factors. We found that IgG aCL was associated with developing pregnancy-induced hypertension (PIH) (odds ratio 11.4, 95% CI 2.7-48); IgG aPE with PIH (8.3, 2.4-29), severe PIH (20.4, 4.5-91), and premature delivery (PD) (12.7, 3.1-50); and LA with PD (11.0, 2.8-44) and low birth weight (8.0, 2.1-31). The combinations of IgG aPE plus IgG aCL (17.5, 4.7-66.7) or IgG aPE plus LA (22.2, 5.4-909) measurements predicted severe PIH with 30.8% sensitivity and 99.2% specificity. We conclude that aPL measurements during early pregnancy may be useful in predicting adverse pregnancy outcome.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0165-0378", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yamada, Hideto"}], "nameIdentifiers": [{"nameIdentifier": "459340", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Atsumi, Tatsuya"}], "nameIdentifiers": [{"nameIdentifier": "459341", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kobashi, Gen"}], "nameIdentifiers": [{"nameIdentifier": "459342", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohta, Kaori"}], "nameIdentifiers": [{"nameIdentifier": "459343", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koike, Takao"}], "nameIdentifiers": [{"nameIdentifier": "459344", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Minakami, Hisanori"}], "nameIdentifiers": [{"nameIdentifier": "459345", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "459346", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小橋 元", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "459347", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "太田 薫里", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "459348", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/46137", "pubdate": {"attribute_name": "公開日", "attribute_value": "2011-07-14"}, "publish_date": "2011-07-14", "publish_status": "0", "recid": "46137", "relation": {}, "relation_version_is_last": true, "title": ["Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes."], "weko_shared_id": -1}
Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes.
https://repo.qst.go.jp/records/46137
https://repo.qst.go.jp/records/46137ea1f04cd-95ab-47bd-bd98-c55df0366a23
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2011-07-14 | |||||
タイトル | ||||||
タイトル | Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Yamada, Hideto
× Yamada, Hideto× Atsumi, Tatsuya× Kobashi, Gen× Ohta, Kaori× Koike, Takao× Minakami, Hisanori× et.al× 小橋 元× 太田 薫里 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Antiphospholipid antibody (aPL) is associated with thromboembolism. There is scant evidence of a relationship between the aPL profile and serious adverse pregnancy outcome. The aim of this study was to assess whether aPL measurements during early pregnancy were useful in predicting a serious adverse pregnancy outcome. In this prospective study, we measured aPLs, including lupus anticoagulant (LA), IgG, IgM, IgA anticardiolipin antibody (aCL), IgG, IgM phosphatidylserine-dependent antiprothrombin antibody, and IgG kininogen-dependent antiphosphatidylethanolamine antibody (aPE) during the first trimester in a consecutive series of 1155 women. The 99 th percentile cut-off values in each aPL were determined using samples from 105 women who did not exhibit any pregnancy morbidity. We assessed the predictive risk of a serious adverse pregnancy outcome adjusted for confounding factors. We found that IgG aCL was associated with developing pregnancy-induced hypertension (PIH) (odds ratio 11.4, 95% CI 2.7-48); IgG aPE with PIH (8.3, 2.4-29), severe PIH (20.4, 4.5-91), and premature delivery (PD) (12.7, 3.1-50); and LA with PD (11.0, 2.8-44) and low birth weight (8.0, 2.1-31). The combinations of IgG aPE plus IgG aCL (17.5, 4.7-66.7) or IgG aPE plus LA (22.2, 5.4-909) measurements predicted severe PIH with 30.8% sensitivity and 99.2% specificity. We conclude that aPL measurements during early pregnancy may be useful in predicting adverse pregnancy outcome. | |||||
書誌情報 |
Journal of Reproductive Immunology 巻 79, 号 2, p. 188-195, 発行日 2009-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0165-0378 |